The potential role of the angiotensin subtype 2 receptor in cardiovascular protection

Current Hypertension Reports

Volumn 11, Issue 4, 2009, Pages 260-262

  Siragy, Helmy M ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ARACHIDONIC ACID; BRADYKININ; CYCLIC GMP; INOSITOL 1,4,5 TRISPHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PHOSPHOLIPASE A2; PHOSPHOLIPASE C; PRORENIN; PRORENIN RECEPTOR; RENIN; SODIUM; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN II; CELL SURFACE RECEPTOR;

ATHEROSCLEROSIS; ENZYME ACTIVATION; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; NATRIURESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RENIN RELEASE; REVIEW; SIGNAL TRANSDUCTION; SODIUM EXCRETION; VASODILATATION; ARTERIOSCLEROSIS; BIOSYNTHESIS; DRUG EFFECT; KIDNEY DISEASE; PATHOPHYSIOLOGY; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; KIDNEY DISEASES; NITRIC OXIDE; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, CELL SURFACE; RENIN-ANGIOTENSIN SYSTEM; VASODILATION; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS;

EID: 67651108610     PISSN: 15226417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11906-009-0044-3     Document Type: Review

References (34)

1. Naseem RH, Hedegard W, Henry TD, et al.: Plasma cathepsin D isoforms and their active metabolites increase after myocardial infarction and contribute to plasma renin activity. Basic Res Cardiol 2005, 100: 139-146.
2. Borges JC, Silva JA Jr, Gomes MA, et al.: Tonin in rat heart with experimental hypertrophy. Am J Physiol Heart Circ Physiol 2003, 284: H2263-H2268.
3. Borland JA, Kelsall C, Yacoub MH, Chester AH: Expression, localization and function of ACE and chymase in normal and atherosclerotic human coronary arteries. Vascul Pharmacol 2005, 42: 99-108.
4. Siragy HM: AT1 and AT2 receptoR in the kidney: role in health and disease. Semin Nephrol 2004, 24: 93-100.
5. Nguyen G, Burcklé CA, Sraer JD: Renin/prorenin-receptor biochemistry and functional significance. Curr Hypertens Rep 2004, 6: 129-132.
6. Guy JL, Jackson RM, Jensen HA, et al.: Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J 2005, 272: 3512-3520.
7. Faria-Silva R, Duarte FV, Santos RA: Short-term angiotensin(1-7) receptor Mas stimulation improves endothelial function in normotensive rats. Hypertension 2005, 46: 948-952.
8. Siragy H, Huang J, Lieb DC: The development of the direct renin inhibitor aliskiren: Treating hypertension and beyond. Expert Opin Emerg Drugs 2008, 13: 417-430.
9. Siragy HM, Xue C, Abadir P, Carey RM: Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 2005, 45: 133-137.
10. Nguyen G, Delarue F, Burcklé C, et al.: Pivotal role of the renin/ prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109: 1417-1427.
11. Siragy HM, Huang J: Renal (pro)renin receptor upregulation in diabetic rats through enhanced angiotensin AT1 receptor and NADPH oxidase activity. Exp Physiol 2008, 93: 709-714.
12. Suzuki F, Hayakawa M, Nagakawa T, et al.: Human prorenin has "gate and handle" regions for its nonproteolytic activation. J Biol Chem 2003, 278: 22217-22222.
13. Burcklé CA, Danser AHJ, Müller DN, et al.: Elevated blood pressure and heart rate in human renin receptor transgenic rats. Hypertension 2006, 47: 552-556.
14. Ichihara A, Suzuki F, Nakagawa T, et al.: Prorenin receptor blockade inhibits development of glomerulosclerosis in diabetic angiotensin II type 1a receptor deficient mice. J Am Soc Nephrol 2006, 17: 1950-1961.
15. de Gasparo M, Catt KJ, Inagami T, et al.: International Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52: 415-472.
16. Siragy HM, de Gasparo M, Carey RM: Angiotensin type 2 receptor mediates valsartan-induced hypotension in conscious rats. Hypertension 2000, 35: 1074-1077.
17. Siragy HM, Carey RM: The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 1997, 100: 264-269.
18. Siragy HM, Carey RM: The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3',5'-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 1996, 97: 1978-1982.
19. Nouet S, Amzallag N, Li JM, et al.: Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 2004, 279: 28989-28997.
20. Hannan RE, Davis EA, Widdop RE: Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: Involvement of bradykinin and nitric oxide. Br J Pharmacol 2003, 140: 987-995.
21. Widdop RE, Matrougui K, Levy BI, Henrion D: AT2 receptor-mediated relaxation is preserved after long-term AT1 receptor blockade. Hypertension 2002, 40: 516-520.
22. Ozono R, Wang ZQ, Moore AF, et al.: Expression of the subtype 2 angiotensin (AT2) receptor protein in rat kidney. Hypertension 1997, 30: 1238-1246.
23. Siragy HM, Carey RM: Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 1999, 33: 1237-1243.
24. Savoia C, Touyz RM, Volpe M, Schiffrin EL: Angiotensin type 2 receptor in resistance arteries of type 2 diabetic hypertensive patients. Hypertension 2007, 49: 341-346.
25. Gilles R, Vingerhoedt N, Howes J, et al.: Increase in systemic blood pressure during intra-arterial PD123319 infusion: Evidence for functional expression of angiotensin type 2 receptors in normal volunteers. Blood Press 2004, 13: 110-114.
26. Siragy HM, Inagami T, Carey RM: NO and cGMP mediate angiotensin AT2 receptor-induced renal renin inhibition in young rats. Am J Physiol Regul Integr Comp Physiol 2007, 293: R1461-R1467.
27. Siragy HM, Inagami T, Ichiki T, Carey RM: Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor. Proc Natl Acad Sci U S A 1999, 96: 6506-6510.
28. Padia SH, Howell NL, Siragy HM, Carey RM: Renal angiotensin type 2 receptors mediate natriuresis via angiotensin III in the angiotensin II type 1 receptor-blocked rat. Hypertension 2006, 47: 537-544.
29. + - ATPase activity via a NO/ cGMP-dependent pathway. Am J Physiol Renal Physiol 2006, 290: F1430-F1436.
30. Hakam AC, Hussain T: Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats. Hypertension 2006, 47: 1117-1124.
31. Sales VL, Sukhova GK, Lopez-Ilasaca MA, et al.: Angiotensin type 2 receptor is expressed in murine atherosclerotic lesions and modulates lesion evolution. Circulation 2005, 112: 3328-3336.
32. Dandapat A, Hu CP, Chen J, et al.: Over-expression of angiotensin II type 2 receptor (agtr2) decreases collagen accumulation in atherosclerotic plaque. Biochem Biophys Res Commun 2008, 366: 871-877.
33. Oishi Y, Ozono R, Yoshizumi M, et al.: AT2 receptor mediates the cardioprotective effects of AT1 receptor antagonist in post-myocardial infarction remodeling. Life Sci 2006, 80: 82-88.
34. Jugdutt BI, Menon V: AT2 receptor and apoptosis during AT1 receptor blockade in reperfused myocardial infarction in the rat. Mol Cell Biochem 2004, 262: 203-214.